Silverback Therapeutics shares owned by Quadrant Capital
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Quadrant Capital
from 13F filings
Historical chart of Quadrant Capital investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Silverback Therapeutics by Quadrant Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.9k | 347 | 5.48 |